Nebius Group shares surge after Citron Research endorsement

On Monday, Nebius Group (NASDAQ:NBIS) experienced a notable increase in its stock price following positive remarks from Citron Research. The investment firm took to social media to express its bullish stance on Nebius Group, highlighting the company's potential in the artificial intelligence sector and its current undervaluation compared to its peer, CoreWeave. According to InvestingPro, investors seeking detailed valuation metrics and comprehensive analysis can access the Pro Research Report, which provides expert insights on over 1,400 US stocks.

Citron Research's tweet emphasized their strong belief in Nebius Group's prospects, stating, "Citron pounding the table that $NBIS is poised to be the next AI Wall Street darling. A sleeper with no analyst coverage yet, the market hasn’t caught on to its massive potential—or its undervaluation vs. CoreWeave." They speculated that if Nebius Group were to trade at a 50% discount to CoreWeave's multiple, the stock could be valued at $60.

The tweet also praised Nebius Group's CEO, Arkady Volozh, referring to him as "the real deal" and mentioning the strategic investment by Nvidia Corporation (NASDAQ:NVDA ), which was not made spontaneously but was the result of a decade-long familiarity with Nebius Group. InvestingPro data shows NVDA's own impressive financial metrics, including a perfect Piotroski Score of 9 and remarkable revenue growth of 152% in the last twelve months. Citron Research further remarked on the company's strong financial position, calling it a "Fortress balance sheet."

Following the tweet from Citron Research, Nebius Group's shares reached a session high, climbing 9.6%. This movement in the stock price underscores the impact that endorsements from recognized investment research firms can have on market perception and investor sentiment. For deeper insights into market movements and valuations, InvestingPro offers comprehensive financial analysis and real-time market intelligence.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Source: Investing.com